<code id='D6F2446869'></code><style id='D6F2446869'></style>
    • <acronym id='D6F2446869'></acronym>
      <center id='D6F2446869'><center id='D6F2446869'><tfoot id='D6F2446869'></tfoot></center><abbr id='D6F2446869'><dir id='D6F2446869'><tfoot id='D6F2446869'></tfoot><noframes id='D6F2446869'>

    • <optgroup id='D6F2446869'><strike id='D6F2446869'><sup id='D6F2446869'></sup></strike><code id='D6F2446869'></code></optgroup>
        1. <b id='D6F2446869'><label id='D6F2446869'><select id='D6F2446869'><dt id='D6F2446869'><span id='D6F2446869'></span></dt></select></label></b><u id='D6F2446869'></u>
          <i id='D6F2446869'><strike id='D6F2446869'><tt id='D6F2446869'><pre id='D6F2446869'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:hotspot    Page View:6959

          Has AI really solved biology? What can machines teach us about medicine? And what’s a digital twin?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. It’s our all-AI episode. First, STAT’s Casey Ross joins us to explain his reporting on how researchers and pharmaceutical firms are using the technology to find new drug targets, design therapies, and improve clinical trials. Then, we talk to Joel Dudley, a partner at the venture firm Innovation Endeavors, about how to discern promising ideas from wastes of time when it comes to AI in biotech.

          advertisement

          For more on what we cover, here’s the latest on AI in drug development; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          Wikipedia

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          House looks to weaken Medicare negotiation
          House looks to weaken Medicare negotiation

          TheHouseofRepresentativesishavingahearingontwobillsthatcouldweakenMedicare'sdrugpricenegotiationproc

          read more
          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more

          Schizophrenia gene found to be linked to cells' energy dysfunction

          Toscientists'surpriseinanewstudy,acommongeneticdeletioninschizophreniacaseswaslinkedtoproblemsinmito